Becker's Healthcare August 1, 2024
Private equity firms TowerBrook Capital Partners and Clayton, Dubilier & Rice are acquiring R1 RCM in a deal valued at $8.9 billion.
An R1 RCM special committee had set a July 31 deadline for interested parties to submit fully-financed bids in connection with its review process. R1 formed the special committee of independent directors in February in the wake of two major shareholders mulling an offer to take the company private.
The transaction was unanimously approved by the special committee, according to an Aug. 1 R1 RCM news release. An investment vehicle controlled by TowerBrook currently owns about 36% of R1’s outstanding shares. Under the terms of the agreement, TowerBrook and CD&R will acquire all the outstanding common stock...
Today's Sponsors
Today's Sponsor